PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.
Akturk, Halis Kaan
PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity. [electronic resource] - The Journal of clinical endocrinology and metabolism 10 2018 - 3589-3592 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
1945-7197
10.1210/jc.2018-01430 doi
Antibodies, Monoclonal--adverse effects
Antineoplastic Agents, Immunological--adverse effects
Autoimmunity--drug effects
Diabetes Mellitus, Type 1--chemically induced
Graft Rejection--etiology
Humans
Immunotherapy--adverse effects
Kidney Transplantation--adverse effects
Male
Melanoma--drug therapy
Middle Aged
Prognosis
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Skin Neoplasms--drug therapy
PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity. [electronic resource] - The Journal of clinical endocrinology and metabolism 10 2018 - 3589-3592 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
1945-7197
10.1210/jc.2018-01430 doi
Antibodies, Monoclonal--adverse effects
Antineoplastic Agents, Immunological--adverse effects
Autoimmunity--drug effects
Diabetes Mellitus, Type 1--chemically induced
Graft Rejection--etiology
Humans
Immunotherapy--adverse effects
Kidney Transplantation--adverse effects
Male
Melanoma--drug therapy
Middle Aged
Prognosis
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Skin Neoplasms--drug therapy